ePatient 2020 - Changing the Future of Diabetes Management

April 30, 2020


Moderator: Vu Van, RVP @ Livongo


  • Nicolas Cuttriss, MD, MPH, FAAP, Lead Global Health, Clinical Assistant Professor @ Stanford University
  • Gopika Gangupantula, MD, FAAFP, BC-ADM, CDE, Diabetologist, President @ Valley Diabetes & Obesity
  • Anmol Madan, Chief Data Scientist @ Livongo


Diabetes is a complex, chronic disease that affects over 425 million people globally as of 2017.  In 2018, 34.2 million Americans, or 10.5% of the population, had diabetes.  It means that one person in eleven has to manage the chronic condition on a daily basis for the rest of their lives. Diabetes is the major cause of blindness, amputations, kidney failure, heart attack, and stroke. As of 2017, we spent over $340 billion managing complications caused by Diabetes.  Clearly, the epidemic continues to consume our health, lives and the economy. While there are lifelong challenges, the good news is diabetes can be controlled.

Rapid advances in new medications and insulin therapy enable better management of the age-old disease. From the long acting insulins and fast acting insulins, inhaled insulin to ultra rapid insulins, smart insulins and oral insulins to the advances in glucose monitors with longer lasting CGMs and the smartphones that provide real-time feedback for patients to track their blood sugars are the new frontiers in its management.  To move the needle in improving the condition across the country, however, requires innovations across connected care, affordability & cost efficiencies, whole person care and insurance coverage. It is important to understand the changing roles required for the person with diabetes, the clinician who strives to provide their care, the employer and the insurance company who are vested in the health of their employees.

Speaker Bios

Nicolas Cuttriss, MD, MPH, FAAP

Lead Global Health, Clinical Assistant Professor
Stanford University

Dr. Cuttriss is pediatric endocrinologist, public health professional and social entrepreneur committed to solving complex large-scale social health problems. In particular, Dr. Cuttriss has a unique dedication to improving the quality of life of people living with diabetes and chronic pediatric endocrine conditions and to training the next generation of leaders and global citizens. Dr. Cuttriss’ leadership in the conceptual design and implementation of grass-roots health outreach and training programs have gained international attention. Dr. Cuttriss initially received start-up funding from Ashoka’s Youth Venture through his founding of and leadership role in AYUDA (American Youth Understanding Diabetes Abroad). Dr. Cuttriss developed an innovative peer-based service learning delivery model in diabetes for training, placing, and supervising student volunteers abroad. Dr. Cuttriss has supported diabetes outreach initiatives in over 10 countries, trained and placed over 700 students abroad and raised and delivered over $10 million dollars in program services. Dr. Cuttriss served as the first pediatric endocrinologist for University of New Mexico Project ECHO Institute ENDO teleECHO clinic to democratize specialty knowledge and expand patients’ access to critical care and services in rural and underserved communities. He joined Stanford University to further evaluate and scale the model to include type 1 diabetes and he now serves as Director of the Project ECHO Diabetes Clinic at Stanford University. Dr. Cuttriss’  primary research interests center around value-based care in diabetes and chronic disease and telehealth. As a practicing pediatric endocrinologist, Dr. Cuttriss has special interest in telehealth and supports underserved diabetes communities in the United States and globally.

Gopika Gangupantula, MD, FAAFP, BC-ADM, CDE

Diabetologist, President
Valley Diabetes & Obesity

Dr. Gopika Gangupantula is a Fellowship Trained Diabetologist and Board Certified Family Physician based in Modesto. Dr Gangupantula pursued her passion for Diabetes and has received Fellowship Certification in Diabetes from East Carolina University, North Carolina.  She specializes in intensive insulin treatment including Insulin pump management, oral hypoglycemic agent management, non-insulin injectable treatment and Obesity management

Dr. Gangupantula started her own practice, Valley Diabetes & Obesity in Modesto in 2017 focusing on the severely underserved community. She is active in the community providing awareness and education in Advanced Diabetes management and also provides training to Family Practice Residents at her clinic. Her goal is to setup Valley Diabetes & Obesity as a Diabetes Center of Excellence, available as a resource for all members of the community with the best of care, education and social support.  She partners with the local health systems, device and pharmaceutical companies to enable patient assistance programs for insulin and CGMs.

She is committed to helping patients maintain a healthy lifestyle through education and diabetes management services for adults, children, and pregnant women.  She is a key participant in Stanford’s Project ECHO for Diabetes intervention program to collaborate and deliver increased access to Diabetes care for the under-served residents of Stanislaus and San Joaquin counties.

Previously, Dr Gangupantula was a Clinical Director of Specialized Diabetes Care at Golden Valley Health Centers, an FQHC focused on community-based healthcare, establishing Diabetes specialty clinics at various locations in the central valley. Prior to that, she was the Diabetes Champion at Kaiser Permanente, Modesto.

Anmol Madan

Chief Data Scientist

Anmol Madan is Chief Data Scientist at Livongo where he is responsible for machine learning and data science across all of Livongo’s products and services, to help people be the best versions of themselves. Anmol previously co-founded Ginger.io, an AI-driven behavioral health system that provides access to 24/7 coaching, therapy and psychiatry, and served as its Chief Executive Officer for 7 years. Under his leadership, Ginger.io built an AI-driven member and clinical product, established a high-growth distribution model with employers, became broadly available as an in-network health-plan benefit, and raised $35 million in venture funding from top-tier Silicon Valley VCs. Anmol received a Ph.D. in machine learning applied to human behavior from the MIT Media Lab, and has authored 20+ scientific publications (Science, AAAI, Ubicomp, NIPS), and over a dozen patents related to machine learning in healthcare. He has been recognized as one of the 100 Most Creative people, and as a World Economic Forum Technology Pioneer.

Vu Van


Vu Van works with senior-level IDN/health systems/hospital executives and health plans with a mutual goal of improving clinical outcomes, reducing medical costs and ultimately empowering those with chronic conditions to live better and healthier lives. Vu has In-depth knowledge of partnering with [Healthcare Systems] Large Hospitals, IDNs, ACOs, Specialists, and Primary Care. [Employers] Large Enterprise (5000+) Employers, and C-Suite/Executives. He has an award-winning track record of identifying, developing and implementing market expansion activities - Growing client relationships and leading teams delivering end-to-end solutions.